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1. INTRODUCTION 
Neutrophilic polymorphonuclear (PMN) leuko- 
cytes react with increased adherence, oxidative 
metabolism, chemotaxis, degranulation and bacte- 
rial killing after contact with substances generated 
in an inflammatory or infected site, e.g., the C5a- 
fragment and bacterial products, such as fMLP. 
One of the earliest recognized manifestations of an 
acute inflammatory response is granulocyte adhe- 
sion to the vascular endothelium, adjacent to the 
inflammatory focus. This increased adhesiveness 
may also lead to an increment in granulocyte ag- 
gregation, which can be measured in vitro in an 
aggregometer. 
A novel group of mediators of inflammation are 
called leukotrienes [l]. These are formed within 
PMNs after stimulation with fMLP or the calcium 
ionophore A23 187 by a lipoxygenase-dependent 
oxygenation of arachidonic acid. The generated 
epoxide leukotriene 4 (LTA4) is unstable and 
converted to leukotriene B4 (LTB4) by enzymatic 
hydrolysis. Two other 5,12-dihydroxy isomers 
(compounds IJI) can also be formed by a non- 
enzymatic hydrolysis of LTA,+ 
LTB4 can be further metabolized to a w-hydrox- 
ylated compound (20-OH-LTB4) and the corre- 
sponding dicarboxylic acid, (20-COOH-LTB4) [2]. 
Abbreviations: LTB4, leukotriene B4 (5(s), 12(R)-dihy- 
droxy-6,8,10,14-eicosatetraenoic acid); fMLP, formyl- 
methionyl-leucyl-phenylalanine; HEPES, N-2-hy- 
droxyethylpiperazine-N’-2-ethanesulfonic a id; HPLC, 
high performance liquid chromatography 
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LTB4 stimulates neutrophil migration (in vitro 
and in vivo), aggregation and degranulation (3-61. 
Compounds I and II also induce migration and 
adherence but are less potent than LTB4 and cause 
only a marginal degranulation [7,8]. 20-OH-LTB4 
and 20-COOH-LTB4 also stimulate migration but 
to a lesser degree than LTB4 [9]. This report con- 
cerns effects on granulocyte aggregation by several 
lipoxygenase-dependent oxygenation products of 
arachidonic acid. 
2. METHODS 
2.1. Preparations of leukotrienes and related com- 
pounds 
All compounds tested in this study were ob- 
tained from incubations of human leukocytes. The 
leukocytes were prepared from white-blood-cell 
concentrates (buffy coat), kindly supplied by the 
Blood Central at the Karolinska Hospital. For 
preparation of cells, see [lo]. In short, the pro- 
cedure involves dextran sedimentation, am- 
monium-chloride-induced lysis of red cells and 
centrifugation. For incubation cells were sus- 
pended in Dulbecco’s PBS, or in HBSS buffered 
with HEPES. These cells were incubated with 
arachidonic acid with or without ionophore 
A23187. To obtain LTB4 [ 1 l] cells were incubated 
with arachidonic acid plus the ionophore A23 187. 
These incubations also produced the w-oxidation 
products (i.e., 20-OH and the 20-COOH deriva- 
tives) of LTB4 [2,12]. The 20-COOH derivative of 
LTB4 was also obtained in incubations of leuko- 
cytes with the tripeptide fMLP [13]. Compounds 
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thus obtained were purified by acidic ether extrac- 
tion, column chromatography on silica gel and 
HPLC. For separation of LTB4 straight phase 
HPLC (SP-HPLC) was performed. The com- 
pounds were converted to the methyl esters before 
SP-HPLC. An additional purification on reverse 
phase HPLC (RP-HPLC) was performed. Here- 
after, the free acid forms were regenerated by 
saponification and again purified on RP-HPLC. 
Quantitation of thus prepared leukotrienes was 
based on UV-spectroscopy. The absorption max- 
ima around 270 nm were used, and an extinction 
coefficient of 40000 has been assumed. In later 
determinations of LTB4, however, the extinction 
coefficient 50 000 was used [ 141. 
2.2. Neutrophil isolation 
Purified human PMN leukocytes (of ~95% pu- 
rity) were isolated from heparinized (10 IU/ml- 
without preservative) blood. The blood was 
layered on a discontinous Percoll gradient (Phar- 
macia Fine Chemicals, Uppsala). The separation 
was performed by a modification of the method in 
[15]. To the stock iso-osmotic Percoll was added a 
solution consisting of 1 part of HBSS/ 1 part 
0.075 M Tris-HCl to prepare the desired densities, 
calculated to be 1.0990 and 1.0776 g/ml, respec- 
tively. The osmolarity was found to be 280- 
310 mOs/kg HZ0 and pH 7.5-7.6. The gradient 
was centrifuged at 4OOxg for 5 min at 20°C. The 
platelet-rich plasma supematant was then re- 
moved and centrifugation was continued for an- 
other 20 min at 800 x g. The granulocyte band 
was carefully removed and washed twice in 
heparinized 0.9% saline before lysis with am- 
monium chloride (0.155 M N&Cl) for 5 min to 
free the PMNs of contaminating erythrocytes. Pu- 
rified PMN leukocytes were suspended in Hank’s 
balanced salt solution with 1% human serum al- 
bumin (HBSS-A) at 1.15 x 10’ cells/ml. 
2.3. Neutrophil aggregation 
PMN aggregometry was performed as in [ 161. A 
standard platelet aggregometer (Model 300 BD, 
Payton Assoc., Buffalo NY) was used. To a sil- 
iconized cuvette, containing a stir bar revolving at 
900 rev./min was added 0.45 ml PMN suspension 
(1.15 X 107 cells/ml). After 2 min delay to allow 
warming of cells to 37°C 50 ~1 of the aggregant 
IMLP or lipoxygenase products were added, dis- 
solved in 0.1% ethanol in HBSS. The resulting 
changes in light transmission were recorded as AT. 
To provide the necessary amplification for a well- 
defined aggregation wave the aggregometer/rec- 
ord system was calibrated with a PMN suspension 
diluted 50% (v/v) with HBSS. The tested ag- 
gregants were suspended in HBSS in serial dilu- 
tions ranging from 10-5-10-11 M. 
3. RESULTS 
The maximum change in light transmission 
(AT), after stimulation with different lipoxygenase 
products or fMLP, is given in fig. 1. LTB4 induces 
aggregation to a greater degree than any of the 
other lipoxygenase products tested here. However, 
fMLP causes a more pronounced maximal light 
transmission than the leukotrienes. The peak re- 
sponse occurs for LTB4 at 10-7 M and for fMLP 
at 10-h M, but, while the lowest concentration of 
fMLP that induces aggregation is 10-g M, LTB4 
has some effect even at lo-*0 M. Of the other 
compounds tested here 20-OH-LTB4 was more ac- 
tive than 20-COOH-LTB4, and almost as active as 
LTB4, but did not induce any aggregation at lo-to 
M. Compounds I and II also had weak aggregating 
activity. 
NUTROPHL AGGREGATION 
Fig.1. PMN aggregation after stimulation with fMLP 
and the lipoxygenase products. The results are expressed 
as means and SE values of the maximum change in light 
transmission (AI). PMNs were obtained from at least 3 
different healthy subjects. When HBSS without fMLP 
or leukotrienes was added no aggregation was induced. 
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4. DISCUSSION REFERENCES 
Aggregometry is a sensitive in vitro method for 
detecting inflammatory mediators such as fMLP, 
C5a and leukotrienes [17,18]. According to [ 191 it 
might be the most sensitive technique known to 
determine C5a and, hence, complement activation. 
In vivo PMN aggregation is believed to be a mech- 
anism in the adult repiratory distress syndrome, a 
pulmonary dysfunction occurring in patients sub- 
jected to hemodialysis or cardiopulmonary bypass, 
and, possibly also, myocardial infarction [20]. 
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